| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $665,292 ) |
| | 2026 | 2026 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R44NS110114 | Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms | 001 | 4 | NIH | 9/14/2026 | $665,292 |
| | 2026 | 2025 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R44NS110114 | Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms | 000 | 3 | NIH | 8/24/2026 | $0 |
| | 2026 | 2023 | ENDOMIMETICS, INC. | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R43AR083762 | Bionanomatrix coating to enhance antibacterial effects while reducing inflammation of knee joint implants | 000 | 1 | NIH | 2/26/2026 | $0 |
| | 2026 | 2022 | ENDOMIMETICS, INC. | 2000 9TH AVE S | BIRMINGHAM | AL | 35205-2708 | JEFFERSON | USA | R44DK109789 | Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | 000 | 5 | NIH | 1/6/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $853,282 ) |
| | 2025 | 2025 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R44NS110114 | Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms | 000 | 3 | NIH | 9/19/2025 | $853,282 |
| | 2025 | 2024 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R43HL176310 | Atherosclerosis assay development for drug efficacy and cytotoxicity screening | 000 | 1 | NIH | 8/11/2025 | $0 |
| | 2025 | 2022 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R43HL160311 | Dual-action drug coated balloon to mitigate neointimal hyperplasia and promote endothelialization. | 000 | 1 | NIH | 8/6/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $1,224,238 ) |
| | 2024 | 2024 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R44NS110114 | Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms | 000 | 2 | NIH | 9/12/2024 | $920,119 |
| | 2024 | 2024 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R43HL176310 | Atherosclerosis assay development for drug efficacy and cytotoxicity screening | 000 | 1 | NIH | 9/16/2024 | $304,119 |
| | 2024 | 2023 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R43AR083762 | Bionanomatrix coating to enhance antibacterial effects while reducing inflammation of knee joint implants | 000 | 1 | NIH | 11/15/2023 | $0 |
| | 2024 | 2022 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R43HL160311 | Dual-action drug coated balloon to mitigate neointimal hyperplasia and promote endothelialization. | 000 | 1 | NIH | 6/17/2024 | $0 |
| | 2024 | 2022 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R44DK109789 | Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | 000 | 5 | NIH | 9/10/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $292,643 ) |
| | 2023 | 2023 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R43AR083762 | Bionanomatrix coating to enhance antibacterial effects while reducing inflammation of knee joint implants | 000 | 1 | NIH | 9/19/2023 | $292,643 |
| | 2023 | 2022 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R43HL160311 | Dual-action drug coated balloon to mitigate neointimal hyperplasia and promote endothelialization. | 000 | 1 | NIH | 5/26/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,475,068 ) |
| | 2022 | 2022 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R44DK109789 | Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | 000 | 5 | NIH | 7/8/2022 | $977,762 |
| | 2022 | 2022 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R43HL160311 | Dual-action drug coated balloon to mitigate neointimal hyperplasia and promote endothelialization. | 000 | 1 | NIH | 3/30/2022 | $497,306 |
| | 2022 | 2019 | ENDOMIMETICS LLC | 400 RIVERHILLS BUSINESS PARK | BIRMINGHAM | AL | 35242-5182 | SHELBY | USA | R43NS110114 | Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms | 000 | 1 | NIH | 8/18/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $940,759 ) |
| | 2021 | 2021 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R44DK109789 | Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | 001 | 4 | NIH | 9/15/2021 | $940,759 |
| | 2021 | 2019 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R43NS110114 | Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms | 000 | 1 | NIH | 3/8/2021 | $0 |
| | 2021 | 2018 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R44DK109789 | Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | 000 | 3 | NIH | 3/2/2021 | $0 |
| | 2021 | 2017 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R43HL137515 | Coating to enhance endothelialization after left atrial appendage closure | 000 | 1 | NIH | 3/9/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2017 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R43HL137515 | Coating to enhance endothelialization after left atrial appendage closure | 000 | 1 | NIH | 6/5/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $563,196 ) |
| | 2019 | 2019 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R43NS110114 | Enhanced endothelialization of nanomatrix coated flow diverter for intracranial aneurysms | 000 | 1 | NIH | 2/13/2019 | $563,196 |
| | 2019 | 2017 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R43HL137515 | Coating to enhance endothelialization after left atrial appendage closure | 000 | 1 | NIH | 5/10/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $940,410 ) |
| | 2018 | 2018 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R44DK109789 | Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | 001 | 3 | NIH | 8/2/2018 | $940,410 |
| | 2018 | 2017 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R44DK109789 | Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | 000 | 2 | NIH | 8/2/2018 | $0 |
| | 2018 | 2015 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R43NS095455 | Bionanomatrix coating for brain aneurysm coils to enhance healing | 000 | 1 | NIH | 9/19/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,435,969 ) |
| | 2017 | 2017 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R44DK109789 | Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | 001 | 2 | NIH | 8/11/2017 | -$972,781 |
| | 2017 | 2017 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R43HL137515 | Coating to enhance endothelialization after left atrial appendage closure | 000 | 1 | NIH | 8/28/2017 | $463,188 |
| | 2017 | 2017 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R44DK109789 | Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | 002 | 2 | NIH | 8/14/2017 | $972,781 |
| | 2017 | 2017 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R44DK109789 | Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturation | 000 | 2 | NIH | 8/9/2017 | $972,781 |
| | 2017 | 2016 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R43DK109789 | Nitric oxide releasing nanomatrix wrap to enhance dialysis fistula maturation | 000 | 1 | NIH | 8/1/2017 | $0 |
| | 2017 | 2015 | ENDOMIMETICS, LLC | UNIT 55 1500 FIRST AVE N | BIRMINGHAM | AL | 35203-1879 | JEFFERSON | USA | R43NS095455 | Bionanomatrix coating for brain aneurysm coils to enhance healing | 000 | 1 | NIH | 3/23/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $429,486 ) |
| | 2016 | 2016 | ENDOMIMETICS, LLC | INNOVATION DEPOT UNIT 55 | BIRMINGHAM | AL | 35203 | JEFFERSON | USA | R43DK109789 | Nitric oxide releasing nanomatrix wrap to enhance dialysis fistula maturation | 000 | 1 | NIH | 3/15/2016 | $429,486 |
|
| Issue Date FY: 2015 ( Subtotal = $553,378 ) |
| | 2015 | 2015 | ENDOMIMETICS, LLC | INNOVATION DEPOT UNIT 55 | BIRMINGHAM | AL | 35203 | JEFFERSON | USA | R43NS095455 | Bionanomatrix coating for brain aneurysm coils to enhance healing | 000 | 1 | NIH | 9/18/2015 | $553,378 |
|
|
